icotinamide Adenine Dinucleotide Homeostasis in Cancer Patients
Not Applicable
Recruiting
- Conditions
- cancer
- Registration Number
- JPRN-jRCT1020210066
- Lead Sponsor
- Hakamada Kenichi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients undergoing cancer treatment at Hirosaki university hospital from Dec. 2021.
Subjects must meet the following criteria to be enrolled in this study.
1. Age >20 years.
2. Patients who have been fully informed about the participation in this study and have given written consent of their own free will with full understanding.
Exclusion Criteria
Patients who are judged by the principal investigator to be unsuitable as subjects.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method